Eli Lilly (LLY) Long-Term Investments (2009 - 2026)
Eli Lilly (LLY) reported Long-Term Investments of $3.86 billion for Q2 2026, up 20.2% from $3.21 billion a year earlier and up 23.7% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Long-Term Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly posted Long-Term Investments of $2.8 billion, down 12.9% from FY2024.
- Long-Term Investments has a five-year compound annual growth rate of -1.1% (FY2020 to FY2025).
- By year, Long-Term Investments came in at $3.22 billion in FY2024 (+5.4%), $3.05 billion in FY2023 (+5.2%), $2.9 billion in FY2022 (-9.7%) and $3.21 billion in FY2021 (+8.3%).
- The Q2 2026 figure ranks as the highest quarterly Long-Term Investments since Q1 2018.
- Year over year, Long-Term Investments gained in five of the last eight quarters, with growth averaging 4.0%.
- The high point for year-over-year Long-Term Investments in five years was Q3 2021 (growth of 35.3%); the low point was Q2 2022 (a decline of 25.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.12 billion (Q1 2026), $2.8 billion (Q4 2025) and $2.81 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn | 5.79 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.86 Bn |
| Mar 31, 2026 | 3.12 Bn |
| Dec 31, 2025 | 2.80 Bn |
| Sep 30, 2025 | 2.81 Bn |
| Jun 30, 2025 | 3.21 Bn |
| Mar 31, 2025 | 3.22 Bn |
| Dec 31, 2024 | 3.22 Bn |
| Sep 30, 2024 | 3.20 Bn |
| Jun 30, 2024 | 2.88 Bn |
| Mar 31, 2024 | 3.09 Bn |
| Dec 31, 2023 | 3.05 Bn |
| Sep 30, 2023 | 2.69 Bn |
| Jun 30, 2023 | 2.75 Bn |
| Mar 31, 2023 | 2.75 Bn |
| Dec 31, 2022 | 2.90 Bn |
| Sep 30, 2022 | 2.57 Bn |
| Jun 30, 2022 | 2.59 Bn |
| Mar 31, 2022 | 2.73 Bn |
| Dec 31, 2021 | 3.21 Bn |
| Sep 30, 2021 | 3.35 Bn |
API Access
Eli Lilly Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();